Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...

For two decades, the branded pharma website has been treated as the centerpiece of digital engagement. It has been the polished ‘front door’, where brands prepared to tell their story and hoped ...

Major pharmaceutical companies are pushing ahead with sweeping price increases on hundreds of medicines in the United States, ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

Pharma marketers are about to develop tremendous leg strength thanks to the defensive crouch the Food and Drug Administration has forced them into. By issuing a broadside of 40 Untitled Letters to ...

How would you feel if you knew your doctor was getting paid by big pharma? Would you still trust their medical advice? Every year, pharma and biomedical device companies spend billions on doctors' ...

The pharmaceutical industry is experiencing a profound transformation in how it approaches commercial decision-making and insights delivery with a big wave of technology and AI at the doorstep. Market ...

As media habits evolve and audiences fragment across screens, pharma marketers are reassessing where and how to show up. Traditional channels face increasing pressure, while new environments — ...

Anti-obesity drugs are being considered for a range of addictive behaviors. Pfizer just acquired a next-generation, clinical-stage maker of obesity treatments. This pharma giant is entering the ...

What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 2.6% in the afternoon session after the stock's positive momentum continued as the company agreed to acquire ...